Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Capital Expenditures (2020 - 2022)

Bio Essence (BIOE) has 3 years of Capital Expenditures data on record, last reported at -$49851.0 in Q4 2022.

  • For Q4 2022, Capital Expenditures fell 155.48% year-over-year to -$49851.0; the TTM value through Dec 2023 reached $92049.0, down 8.92%, while the annual FY2023 figure was $3614.0, 3.42% down from the prior year.
  • Capital Expenditures reached -$49851.0 in Q4 2022 per BIOE's latest filing, down from $52053.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $89847.0 in Q4 2021 and bottomed at -$49851.0 in Q4 2022.
  • Average Capital Expenditures over 3 years is $18206.6, with a median of $9537.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: soared 1463.1% in 2021, then tumbled 155.48% in 2022.
  • A 3-year view of Capital Expenditures shows it stood at $5748.0 in 2020, then skyrocketed by 1463.1% to $89847.0 in 2021, then crashed by 155.48% to -$49851.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$49851.0 in Q4 2022, $52053.0 in Q3 2022, and $89847.0 in Q4 2021.